Brief: Theraclion publishes clinical trial results

Theraclion SA

28/08/2017 17:02

Aug 28 (Reuters) - THERACLION SA  ALTHER.PA : 
    * THERACLION REPORTS PUBLICATION OF PROMISING CLINICAL TRIAL 
RESULTS IN A NEW THYROID INDICATION 
    * A REMISSION RATE AT 12 MONTHS EQUAL TO 73.3% (SUPPRESSION 
OF HYPERTHYROIDISM), 
    * NO ALTERATION OF OTHER ANTI-THYROID ANTIBODY LEVELS NOR 
OPHTHALMIC PARAMETERS 
    * A SIGNIFICANT DECREASE IN TITERS OF AUTOANTIBODIES (ANTI 
TSHR) 
    * FEASIBILITY AND PROBABLY FAVORABLE COST EFFECTIVENESS 
COMPARED TO SURGERY FOR ALL PATIENTS WHO RECEIVED SINGLE 
SESSION, BILATERAL PROCEDURE 
 
Source text for Eikon:  ID:nBw72X41wa  
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))